Dissemin is shutting down on January 1st, 2025

Published in

MDPI, Cells, 2(9), p. 352, 2020

DOI: 10.3390/cells9020352

Links

Tools

Export citation

Search in Google Scholar

PPAR-Mediated Toxicology and Applied Pharmacology

Journal article published in 2020 by Yue Xi, Yunhui Zhang, Sirui Zhu, Yuping Luo, Pengfei Xu ORCID, Zhiying Huang
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

Peroxisome proliferator-activated receptors (PPARs), members of the nuclear hormone receptor family, attract wide attention as promising therapeutic targets for the treatment of multiple diseases, and their target selective ligands were also intensively developed for pharmacological agents such as the approved drugs fibrates and thiazolidinediones (TZDs). Despite their potent pharmacological activities, PPARs are reported to be involved in agent- and pollutant-induced multiple organ toxicity or protective effects against toxicity. A better understanding of the protective and the detrimental role of PPARs will help to preserve efficacy of the PPAR modulators but diminish adverse effects. The present review summarizes and critiques current findings related to PPAR-mediated types of toxicity and protective effects against toxicity for a systematic understanding of PPARs in toxicology and applied pharmacology.